$SMR Cashflow Statement | Understand Stock

$SMR

$5.70 +$0.43 (8.16%) Close

$SMR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
OPERATING CASH FLOW
Net loss
Adjustments to reconcile net loss to operating cash flow:
Depreciation
Amortization of intangibles
Equity-based compensation expense
Accrued interest on convertible note payable
Provision for credit losses
Change in fair value of warrant liabilities
Income from investments held in Trust Account
Loss on disposal of property, plant and equipment
Impairment of intangible asset
Net noncash change in right of use assets and lease liabilities
Other changes in assets and liabilities:
Prepaid expenses
Accounts payable
Accrued expenses
Prepaid expenses and other assets
Accounts and other receivables (2025 - $(1,797); 2024 - $(1,013) and 2023 - $(1,134) from related party)
Long-lead material work in process
Accounts payable and accrued expenses (2025 - $0; 2024 - $(4,080) and 2023 - $(3,614) from related party)
Long-lead material liability
Lease liability
Deferred DOE cost share
Deferred revenue
Accrued compensation

Net Cash Used in Operating Activities
INVESTING CASH FLOW
Proceeds from sale of short-term investments
Proceeds from sale of investments
Purchase of short-term investments
Purchase of investments
Insurance proceeds for property, plant and equipment
Purchases of property, plant and equipment
Net Cash (Used) Provided by Investing Activities
FINANCING CASH FLOW
Payment of offering costs
Proceeds from the issuance of common stock, net of issuance fees
Proceeds from exercise of warrants and common share options
Proceeds from exercise of warrants
Proceeds from exercise of common stock options
Total proceeds from exercise of warrants and common share options
Foreign income tax withholding to NCI interests
Payments of Transaction costs
Proceeds from debt issuance
Repayment of debt
Proceeds from short-term borrowings
Repayment of short-term borrowings
Proceeds from sale of convertible preferred units
Proceeds from exercise of options
Repurchase of common units
Issuance of treasury units
Net Cash Provided by Financing Activities

Net Change in Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash:
Beginning of period
End of period
Summary of noncash investing and financing activities:
Assumption of Transaction warrant liabilities
Debt converted to equity
Warrants converted into equity
Conversion of equity options to liability award
Equity issuance fees
Capital expenditures in accounts payable
Increase in lease liability
Conversion of accounts payable to convertible preferred units

Supplemental disclosures of cash flow information:
Cash paid for interest
Cash paid for income taxes

Comments